• Business
    • Global report
  • Regulatory
  • Pharmacovigilance
  • Manufacturing
    • GMP
    • Quality assurance
  • R&D
    • API
    • Excipients
    • Trials
    • Drug Delivery
    • Technology
  • Companies
    • Contract manufacturing
    • Equipment
    • Outsourcing
    • Packaging
    • Supply chain
    • Technology Transfer
  • EIPG Newsletter
    • Technology & Production
    • Regulatory
    • Politics & Business
    • Focus on EU’s Countries
    • News from EIPG
Search
  • Who we are
  • How to use and read
Pharma World
  • Business
    • Global report
  • Regulatory
  • Pharmacovigilance
  • Manufacturing
    • GMP
    • Quality assurance
  • R&D
    • API
    • Excipients
    • Trials
    • Drug Delivery
    • Technology
  • Companies
    • Contract manufacturing
    • Equipment
    • Outsourcing
    • Packaging
    • Supply chain
    • Technology Transfer
  • EIPG Newsletter
    • Technology & Production
    • Regulatory
    • Politics & Business
    • Focus on EU’s Countries
    • News from EIPG
Home Tags Definition

Tag: definition

Verification, review, and check: approximation and implementation in terms of data...

Giuliana Miglierini - 16 October 2019
0

Recent Posts

  • HAZEL® GATEWAY GW-MB1: simplify the validation of recovery times in airlocks
  • EIPG: Upcoming events and a call for consultation
  • The economic footprint of the biotechnology industry in Europe: Focus in Pharma
  • Comments to the public consultation on the new HERA agency
  • Structured dialogue with the EU Commission to prevent shortages

Latest Updates

  • 2018/04 - December

    2018/04 – December

  • 2018/03 – November

  • 2018/02 – June

  • 2018/01 – May

Subscribe to our newsletter

Translate

NCF – Notiziario Chimico Farmaceutico

RSS NCF

  • Commissione UE, la proposta di regolamento SoHO su sangue, cellule e tessuti
  • MedTechEurope, un position paper sull’uso dei documenti guida su MDR e IVDR
  • Medicines for Europe, le raccomandazioni per nuovi modelli di pricing per i farmaci generici
  • La nuova Agenda europea dell’Innovazione
  • Future Health Index 2022, l’obiettivo è digitale
© 2020 Tecniche Nuove Spa • Tutti i diritti riservati. Sede legale: Via Eritrea 21 - 20157 Milano. Capitale sociale: 5.000.000 euro interamente versati. Codice fiscale, Partita Iva e Iscrizione al Registro delle Imprese di Milano: 00753480151